Acquisition highlights of Capital 2B and a snapshot of its key metrics.

Established in 2022, Capital 2B is a venture capital firm. Capital 2B operates as a $75Mn fund that is explicitly geared towards investing in tech and IP-led businesses, primarily putting capital into early stage and growing enterprises that have a strong foundation in science and technology. The firm largely pledges its investments towards the fintech, enterprise services, health tech, advanced hardware & technology, and deeptech segments at both the early and growth stages. To date, Capital 2B has built a portfolio of 13 companies including well-known players such as Avammune Therapeutics, Ahammune Biosciences, SuperMoney, Blubirch, and Leumas.

Funding highlights of Capital 2B and a snapshot of its key metrics.

Investment highlights of Capital 2B and a snapshot of its key metrics.

Capital 2B - A Venture Capital Firm Based Out Of New Delhi

Capital 2B

A snapshot of highlights, scale, and metrics

A Venture Capital Firm Based Out Of New Delhi

Capital 2B - Company Profile & Overview

Disclaimer